Based on this thorough analysis, we conclude that the MR acting specifically in SMCs does not play a substantial role in plaque initiation, progression, or inflammation in the ApoE−/− mouse model of atherosclerosis, and thus the MR in non-SMCs mediates the pro-atherogenic effects of MR activation in this model. Here, NR3C2 is linked to atherosclerosis.